J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M600151-JLR200 on May 15, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600151-JLR200v1
47/8/1739    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahman, M. M.
Right arrow Articles by Fernandes, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahman, M. M.
Right arrow Articles by Fernandes, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 1739-1748, August 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling

Md Mizanur Rahman1, Arunabh Bhattacharya1 and Gabriel Fernandes2

Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900

Published, JLR Papers in Press, May 15, 2006.

1 M. M. Rahman and A. Bhattacharya contributed equally to this work.

2 To whom correspondence should be addressed. e-mail: fernandes{at}uthscsa.edu

Bone destruction is a pathological hallmark of several chronic inflammatory diseases, including rheumatoid arthritis, periodontitis, and osteoporosis. Inflammation-induced bone loss of this sort results from increased numbers of bone-resorbing osteoclasts. Numerous studies have indicated that conjugated linoleic acid (CLA) positively influences calcium and bone metabolism. Gene-deletion studies have shown that receptor activator of nuclear factor-{kappa}B ligand (RANKL) is one of the critical mediators of osteoclastogenesis. In this report, we examine the ability of CLA to suppress RANKL signaling and osteoclastogenesis in RAW264.7 cells, a murine monocytic cell line. Treatment of these cells with RANKL activated nuclear factor-{kappa}B (NF-{kappa}B), and preexposure of the cells to CLA significantly suppressed RANKL-induced NF-{kappa}B activation, including phosphorylation of I-{kappa}B{alpha}, degradation of I-{kappa}B{alpha}, and nuclear translocation of p65. RANKL induced osteoclastogenesis in these monocytic cells, and CLA inhibited RANKL-induced tumor necrosis factor-{alpha} production and osteoclast differentiation, including osteoclast-specific genes such as tartrate-resistant acid phosphatase, cathepsin K, calcitonin receptor, and matrix metalloproteinase-9 expression and osteoclast-specific transcription factors such as c-Fos, nuclear factor of activated T-cells expression, and bone resorption pit formation. CLA also inhibited RANKL-induced activation of mitogen-activated protein kinase p38 but had little effect on c-Jun N-terminal kinase activation. Collectively, these data demonstrate for the first time that CLA inhibits osteoclastogenesis by modulating RANKL signaling. Thus, CLA may have important therapeutic implications for the treatment of bone diseases associated with enhanced bone resorption by excessive osteoclastogenesis.

Supplementary key words lipids • monocytes/macrophages • transcription factors • cytokines • cell differentiation • inflammation • signaling pathways • receptor activator of nuclear factor-{kappa}B ligand

Abbreviations: CLA, conjugated linoleic acid; CTR, calcitonin receptor; EMSA, electrophoretic mobility shift assay; JNK, c-Jun N-terminal kinase; LA, linoleic acid; MAPK, mitogen-activated protein kinase; MMP, matrix metalloproteinase; MNC, multinucleated cell; NFATc1, nuclear factor of activated T-cells; NF-{kappa}B, nuclear factor-{kappa}B; RANKL, receptor activator of nuclear factor-{kappa}B ligand; TNF, tumor necrosis factor; TRAP, tartrate-resistant acid phosphatase


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. E. Butz, G. Li, S. M. Huebner, and M. E. Cook
A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R669 - R676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.